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ABSTRACT 
The aim of this study is to apply the Nutrient Analysis Critical Control Point (NACCP) process to ensure that the 
highest nutrient levels in food can determine a beneficial effect on the health of the consumer. The NACCP 
process involves a sequence of analysis and controls that depart from raw material production to the evaluation 
of the effect of nutrition on health. It is articulated through the following points: 1) identification of nutrient level 
in the food; 2) identification of critical control points (environmental, genetic data, chemical and physical data, 
production technology, distribution and administration); 3) establishing critical limits that can impoverish and 
damage the nutrient; 4) establishing measures to monitor; 5) establishing corrective actions. We selected as bio- 
markers the total phenolic content (TPC) and total antioxidant capacity (TAC) of a genotyped Italian hazelnut 
cultivars (Corylus e avellana L.). We performed a clinical study evaluating: a) nutritional status; b) clinical-bio- 
chemical parameters; c) low density lipoprotein oxidation (LDL-ox); d) the expression level changes of oxidative 
stress pathway genes in the blood cell at baseline and after 40 g/die of hazelnut consumption. In this study, we 
found a significant lowering (p ≤ 0.005) of LDL oxidized proteins, in association with the consumption of 40 g/d 
of hazelnuts. Also, we found a significant variation (p ≤ 0.005) of gene expression of antioxidant and pro-oxidant 
genes, between the intake of dietary with and without hazelnuts. This results support the hypothesis that the 
NACCP process could be applied to obtain significant benefits in terms of primary prevention and for contrib- 
uting to the amelioration of food management at the consumer level. 
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1. Introduction 
The globalization of trade has increased the chances that 
the food produced in one place can affect the health and 
diet of people living in another. The rapid increase of 
knowledge on nutrition, medicine and plant biotechnol- 
ogy has dramatically changed the concepts about food. 
This problem has led to an increased incidence of di- 
abetes, obesity, different cancer and vascular disease,  
physiological problems, as well as other degenerative 
diseases [1]. In the post-genomics era, food is not only 
considered as a reservoir of macronutrients, which serve 
to maintain cellular metabolism, but becomes essential to 
be able to differentiate a good or bad state of health. In 
fact, the close relationship that exists between micron- 
trients and gene expression may underlie the pathophysi- 
ologic phenomena or, in the reverse case, it may become 
the first way to slow the onset of chronic degenerative 
diseases. The aim of this study is to apply the Nutrient  *Corresponding author. 
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Analysis Critical Control Point (NACCP) process to en- 
sure that the highest nutrient levels in food can determine 
a beneficial effect on the health of the consumer. The 
goal of NACCP is to identify a biomarker as an indicator 
of the nutritional quality of food. To apply the NACCP 
process we selected as biomarker the total phenolic con-
tent (TPC) and total antioxidant capacity (TAC) of 
genotyped Italian hazelnut cultivars (manca spazio 
(Corylus avellana) L.). We focused our attention on ha-
zelnuts, as they are rich source of unsaturated fatty acids, 
L-arginine, antioxidants, phytochemicals and because it 
is known that regular nuts consumption may reduce the 
risk of heart disease and other chronic diseases. In par- 
ticular, hazelnuts have a significant place among the 
dried nuts in terms of nutrition and health owing to their 
special composition of fats, protein, carbohydrates, vita- 
mins, minerals, dietary fibers and phenolic antioxidants 
[2]. The nutritional and sensory properties of hazelnuts 
make them a unique and ideal raw material for food 
products [3]. To apply the NACCP process we made a 
clinical study to verify the anti-atherogenic effect of the 
consumption of hazelnuts on low density lipoprotein 
(LDL), evaluating the susceptibility of these molecules to 
oxidation (LDL-ox). Furthermore, we analyzed the ex- 
pression level changes of oxidative stress pathway genes 
in the blood cell after hazelnuts consumption. 
2. Materials and Methods 
2.1. NACCP Process 
The NACCP process involves a sequence of analysis and 
controls that depart from raw material production to the 
evaluation of the effect of nutrition on health. It is arti- 
culated through the following points: 1) identification of 
nutrient level in the food; 2) identification of critical 
control points (environmental, genetic data, chemical and 
physical data, production technology, distribution and 
administration); 3) establishing critical limits that can im- 
poverish and damage the nutrient; 4) establish measures 
to monitor; 5) establishing manca spazio (corrective ac-
tions). The actions of NACCP are: 1) enviromental, 
agronomic, zootechnical analyses; analysis of the nu-
trients (study of the nutraceutical properties); 2) identifi-
cation of natural biomarkers; 3) shelf life; 4) definition of 
cooking modes; 5) study of the effect of the nutrient on 
the consumer; 6) identification of biomarker in humans; 
7) health claims [4]. In the present work, the NACCP 
process was applied to the hazelnut food chain, according 
to the following steps: 1) Chemical and physical analyses; 
2) DNA typing of the hazelnut sample; 3) clinical trials. 
2.2. Chemical and Genetic Analysis  
2.2.1. Samples Preparation 
The analyses were carried out on the Italian hazelnut 
cultivar “Tonda Gentile delle Langhe” (TGL, syn. 
“Tonda Gentile Trilobata”) harvested in a single orchard 
in Piedmont. In-shell hazelnuts were stored at 4˚C until 
analysis. 
2.2.2. Protein, Total Lipid and Moisture Content 
Protein content of hazelnuts was obtained by mineraliza- 
tion in sulfuric acid, steam distillation, acid-base titration. 
The hazelnut total lipid content was measured using the 
analytic technique of solvent extraction according to 
protocol of Ref. [5]. The hazelnut moisture content 
was calculated by gravimetry according to protocol of 
Ref. [6]. 
2.2.3. Total Phenolic Content (TPC) and Total 
Antioxidant Capacity (TAC) 
The amount of total phenolics in triplicate kernel ex- 
tracts was measured following the Folin-Ciocalteu pro- 
cedure, the method of Slinkard and Singleton [7], using 
gallic acid as standard. Total antioxidant capacity was 
determined using the FRAP (Ferric Reducing Antioxi- 
dant Power) assay, according to Benzie and Strain me- 
thod [8], modified by Pellegrini et al. [9]. 
2.2.4. DNA Typing of the Hazelnut Sample 
Hazelnuts were genotyped by analyzing the DNA ob- 
tained from the perisperm, a maternal tissue. The extrac- 
tion was performed as described in Doyle and Doyle [10] 
with minor modifications. A total of eight hazelnut SSR 
loci fully characterized were used: CaT-B107 
(FP: GTAGGTGCACTTGATGTGCTTTAC, 
RP: AACACATATTGA 
TCTTTCAAAGC) CaT-B501 (FP: GAAATTCA 
ATCACACCAATAAAGCA, RP: CCTCCCTTG 
TCCTCATCACTG), CaT-B502 (FP: CTCATGA 
CTGCCCATTTCTCG, RP: AGGCATGCAGGC 
TTCACAC), CaT-B504 (FP: CGCCATCTCCAT 
TTCCCAAC, RP: CGGAATGGTTTTCTGCTTCAG), 
CaT-B505 (FP: AGAGAACGACTTTGTA 
TGACAAGA, RP: TTGAACATTAAATACATC 
ATGTGA), CaT-B507 (FP: CTAGCTCACAGA 
GGAAGTGAT, RP: GCTTCTGGGTCTCCTGCTCA), 
CaT-B508 (FP: GGGTCAAGATTGTAAA 
GTGGGA, RP: GCACTCCATGTGCGTTTTC) [11] and 
CaC-B028 (FP: ATGGAGAGGTATTT 
CAGC, RP: CCTGTTTCTCTTTGTTTTCGAG) [12]. 
PCR was performed as described by Boccacci et al. [13]. 
PCR products were analyzed on a 3130 Genetic Analyzer 
(Applied Biosystems, Foster City, CA, USA). Data were 
processed using Gene Mapper Software (ver. 4.0; Ap- 
plied Biosystems, Foster City, CA, USA) and alleles 
were defined by their size in base pairs, by comparison 
with the standard size (GeneScan-500 LIZ, Applied Bio- 
systems, Foster City, CA, USA). 
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Table 1. Comparison of nutritional indices between Stan- 
dard Diet and Standard Diet plus 40 g/die of hazelnut 
supplementation. 
 Standard Diet Standard Diet with 40 g/d hazelnut p-value 
RMR (kcal) 1056.69 ± 75.68 1318.68 ± 62.24  
RMR (Kjoule) 4423.31 ± 50.85 5520 ± 25.24  
P (g) 48.97 ± 15.21 54.49 ± 20.35 a 
C (g) 143.03 ± 23.46 145.47 ± 29.36 b 
L (g) 36.05 ± 26.51 61.69 ± 27.32 a 
AI 0.20 ± 0.5 0.17 ± 0.7 a 
TI 0.41 ± 1.2 0.32 ± 1.6 a 
RMR = Resting metabolic rate. Pa = protein. Cb = carbohydrates. La = lipids. 
AIa = Atherogenic Index. TIb = Thrombogenicity Index. Values are ex- 
pressed as mean ± standard deviation and maximum and minimum value 
detected. The significant values are expressed as: (a) p < 0.05 and (b) p > 
0.05. 
2.3. Clinical Trials 
2.3.1. Partecipants and Study Design 
A total of 30 participants were recruited by Clinical Nu- 
trition and Nutrigenomic Section of University of Rome 
Tor Vergata. To be eligible for the study, participants had 
to meet the inclusion criteria: they had to be aged be- 
tween 18 and 50 years, with a BMI ≥ 19 Kg/m2. The ex- 
clusion criteria were: hepatitis, autoimmune, cardiovas- 
cular and metabolic diseases. All participants will be 
required to provide written informed consent for the 
study. The experimental design follows the phases of the 
process NACCP. The study was carried out with a cros- 
sover design as follow: a) standard diet (SD) for 4 weeks; 
b) wash out period for 3 weeks; c) SD with 40 g daily 
(g/d) of hazelnuts. Compliance was assessed by 3-d diet 
records (3DDRs) completed during the study.  
Trial Registration: This protocol has been registrated 
by ClinicalTrials.gov ID: NCT01890070. 
2.3.2. Clinical Visit and Nutritional Status 
At baseline, all participants were subjected to evaluation 
of health status. The assessment of nutritional status was 
analyzed by anthropometry and bioelectrical impedance 
analysis. According to standard methods (body weight, 
height, hip and waist circumferences), body weight (kg), 
waist and hip measures were taken according standard 
protocol. Body mass index (BMI) was calculated using 
the formula: BMI = body weight/height2 (kg/m2). Bio- 
electrical impedance analysis was conducted according 
standard protocol with the software provided by the ma- 
nufacturer [14-16]. 
2.3.3. Dietary Assessment and Nutritional 
Intervention 
Standard diet refers to an Italian Mediterranean Diet 
(IMOD). The dietary pattern of each subject was eva- 
luated by nutritional indices: Atherogenic Index (AI), 
Thrombogenic Index (TI) [17,18]. No alcoholic beve- 
rages were allowed on gender by a software DIETO-SYS- 
TEM®. The alimentary diary and nutrient intake were 
analysed using diet analyser software DIETOSYSTEM®. 
2.3.4. Sample Collection and RNA Extraction 
Fasted blood sample was collected and stabilized in 
PAXgene Blood RNA Tubes (PreAnalyti (PreAnalytiX 
Qiagen), Hombrechtikon, Switzerland), and stored at 
−80˚C until the RNA extraction. Total RNA of each col- 
lected sample was purified using the PAXgene Blood 
miRNA Kit according to the manufacturer’s instructions 
(PreAnalytixQiagen, Hombrechtikon, Switzerland). Ali- 
quots of total RNA were then quantified and assessed for 
quality by spectrophotometry (Nanodrop, Wilmington, 
USA) and agarose gel electrophoresis. 
2.3.5. Quantitative Real Time PCR and Data Analysis 
We used a specific RT2 Profiler PCR Arrays (Qiagen, 
Netherlands): for our study we focused our attention on 
Human Oxidative Stress (PAHS-065ZA, Qiagen, Nether- 
lands) pathway. Each qRT-PCR experiment was per- 
formed in triplicate and repeated at least twice, according 
to manifacturer’s instruction (Qiagen, Netherlands). The 
value used to plot relative gene expression was deter- 
mined using the expression Fold Change (FC) = 2−ΔΔCT 
[19], as shown in Figure 1. Raw data were filtered for 
genes that were significantly changed above factor 1.0 
within the 95% confidence interval (p ≤ 0.05) for each 
experiment. Finally, only genes with an absolute FC 
value of at least ± 1.5 and p-value ≤ 0.05 were consi- 
dered as differentially expressed genes. 
2.3.6. Oxidative Status 
Blood samples were collected and stabilized in EDTA. 
The study of the level of oxidation of the organism has 
been studied through the quantification of the protein and 
oxidized LDL from the nutrigenomic study. For the study 
of LDL was used in the ELISA test Mercodia Oxidized 
LDL ELISA (Mercodia Diagnostic, Sweden), according 
to customer protocol. 
2.3.7. Statistical Analysis 
A paired t-test or a non-parametric (Wilcoxon test) were 
performed to evaluate differences before and after nutria- 
tional intervention. All tests were considered significant 
at p ≤ 0.05. Statistical analysis was performed using a 
computer software package SAS version 9.3 (SAS Insti- 
tute, Cary, NC). 
3. Results 
3.1. Chemical and Geneticanalyses 
Chemical and antioxidant capacity analyses were carried  
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Figure 1. Flow diagram of the study. CONSORT diagram of the study. 
 
out on samples of 100 g of TGL hazelnuts. On dry weigth, 
the protein content was 12.9% (±2.5); the total fat content 
was 54.4% (±1.1) and the moisture content was 2.9% 
(±0.3). The hazelnut kernel had a total phenolic content of 
GAE 1.02 ± 0.01 g∙kg−1 and showed a total antioxidant 
capacity (FRAP) of 7.88 ± 0.43 mmol Fe2+/kg, in accor- 
dance with the results by Ghirardello et al. [20]. Genetic 
analysis confirmed that the hazelnuts had the genetic 
profile of the cultivar “Tonda Gentile delle Langhe” at 
all analyzed loci (CaT-B107: 136,154; CaT-B501: 
130,130; CaT-B502: 187,191; CaT-B504: 173,185; 
CaT-B505: 116,128; CaT-B507: 186,192; CaT-B508: 
148,164; CaC-B028: 257,263; alleles are expressed in 
base pairs). 
3.2. Clinical Trial 
Of the 30 initial participants enrolled in the study, 24 
subjects were eligible for the study design. 3 person have 
renounced to participate during the first phase, and 3 did 
not meet the inclusion criteria: one of them measured a 
BMI less than 19, one had diabetes mellitus and one had a 
previous history of ischemic heart disease. The 24 indi- 
viduals followed a standard intervention without hazelnut 
for 4 weeks, and after 3 weeks of washout thy followed a 
standard intervention with 40 g/d of hazelnuts. Figure 2 
show the study design according to the CONSORT flow 
diagram. During the intervention phase was assessed 
compliance of participants, via a recording day-by-day 
for the evaluation of the acceptance of hazelnuts. The de- 
gree of compliance was high in both groups but was 99.4% 
in group with hazelnuts, 94.6% in the group without ha- 
zelnuts (p = 0.002). A comparison between two nutritional 
interventions show a reduction of atherogenic index (AI) and 
thrombogenic index (TI) when consuming hazelnuts (p ≤ 
0.05); the nutritional value of macrontrient intake increased 
after the consumption standard diet plus 40 g of hazelnuts, as 
shown in Table 1. At baseline total sample showed a mean 
age of 31.04 years (±5.88), a height of 169.57 cm (±10.97) 
and an average weight of 66.15 kg (±12.24). It was de- 
tected an average BMI of 22.9 Kg/m2 (±2.6). 
With regard to the subdivision of the sample based on 
obesity, according to the classification of BMI there are 
not obese subjects, but only about 25% of overweight 
subjects. Table 2 shows the nutritional status evaluation 
before and after hazelnut’s supplementation. The only 
anthropometric value shows a significant change is the hip 
circumference (p ≤ 0.05). 
After hazelnuts implementation there is a variation of 
the total body water (p = 0.007), which increases, as well 
as the extra cellular water (p = 0.009). There is a decrease 
in fat mass (p = 0.01), and an increase in lean mass (p = 
0.01). To obtain a comprehensive picture of the transcrip- 
tional changes related to a putative positive effects of 
daily hazelnuts assumption, we analyzed the changes in 
the gene expression profiles of a total of 84 genes involv- 
ed in the oxidative stress pathway as shown in Figure 1. 
After data normalization, considering an absolute fold 
change at least equal to ±1.5 (absolute FC ≥ ±1.5) and a 
p-value ≤ 0.05 we found: 6 genes up-regulated (BNIP3, 
GPX2, GSR, HSPA1A, TTN, TXNRD1) and 5 genes 
down-regulated (CCL5, KRT1, MBL2, PRDX6, SOD1) 
as shown in Figure 3. The values of oxidized LDL show 
a significant decrease (p ≤ 0.005) after SD ± 40 g/d of 
hazelnuts as shown in Figure 4. 
4. Discussion 
Studies focusing on the function of food compounds on 
inflammatory response and oxidative stress have opened 
a new window on chronic non-communicable diseases 
(CNCD) prevention. CNCD are non-infectious and 
non-transmissible among people diseases, of long dura-
tion and slow progression, including obesity, car diovas-
cular diseases, diabetes, chronic kidney disease, osteo-
porosis, sarcopenia, Alzheimer’s disease, and many can-
cers. According to WHO 2011 report [21], the 63% of 
deaths occurred in the world during 2008 were due to 
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Figure 2. Human oxidative stress pathway. Different levels of up and down regulation of the 84 genes analyzed and involved 
in the human oxidative stress. 
 
Table 2. Nutritional status evaluation after Standard Diet 
and Standard Diet plus 40 g/die of hazelnut supplementa- 
tion. 
 M ± SD M ± SD p-value 
 Standard Diet Standard Diet with hazelnuts  
Weight (kg) 67.8 ± 11.35 66.84 ± 10.39 b 
Waist (cm) 76.44 ± 5.12 76.43 ± 6.51 b 
Hips (cm) 97.5 ± 7.49 99.76 ± 10.56 a 
TBW (l) 36.5 ± 6.57 38.08 ± 6.87 a 
ECW (l) 15.66 ± 2.38 16.93 ± 2.76 a 
ICW (l) 20.83 ± 4.48 21.15 ± 4.38 b 
FM (Kg) 16.93 ± 3.21 14.83 ± 3.17 a 
MM kg 34.56 ± 7.34 35.07 ± 7.21 a 
LDL-ox 40.38 ± 6.02 36.99 ±5.45 a 
TBWa = Total Body Water; ECWa = Extra Cellular Water; ICWb = Intra- 
cellular Water; FMa = Fat Mass; MMa = Lean Mass. Values are expressed as 
mean ± standard. The significant values are expressed as: (a) p < 0.05 and (b) 
p > 0.05. 
chronic non-communicable diseases, principally cardio- 
vascular diseases (48%), cancer (21%) chronic obstruc- 
tive pulmonary disease (COPD) (4.2 million). Diabetes 
caused an additional 1.3 million deaths. The prevalence 
of CNCDs is rising rapidly and WHO projections show 
that NCD deaths are projected to increase by 15% glob- 
ally between 2010 and 2020 (to 44 million deaths). The 
effects of diet compounds on metabolic pathways related 
diabetes, cardiovascular diseases, and other CNCD is 
currently under investigation and it is leading the tradi- 
tional nutritional counselling to a more complex ap- 
proach based on gene expression modulation by food. 
Considering together these “food related” pathologies, the 
burden of disease in western countries is impressive [22]. 
The role of diet nutritional quality has been demonstrated 
by several scientific studies that examined the relationship 
between diet, overweightness, obesity and cancer, cardi- 
ovascular disease and diabetes [23]. The Hazard Analysis 
and Critical Control Point (HACCP) (Regulation (EC) N˚ 
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Figure 3. Different significant level of genes expression after 40 g/die hazelnut’s supplementation. The up-regulated genes 
were: BNIP3 (BCL2/adenovirus E1B 19 kDa interacting protein 3; NM_004052), GPX2 (glutathione peroxidase 2; NM_002083), 
GSR (glutathione reductase; NM_000637), HSPA1A (Heat shock 70 kDa protein 1A; NM_005345) TTN (titin; NM_003319) and 
TXNRD1 (thioredoxin reductase 1; NM_003330). The down-regulated genes were: CCL5 (chemokine (C-C motif) ligand 5; 
NM_002985) KRT1 (keratin; NM_006121), MBL2 (mannose-binding lectin (protein C) 2 soluble; NM_000242), PRDX6 (pe-
roxiredoxine 6; NM_004905), SOD1 (superxide dismutase 1, soluble; NM_000454). The significant values are expressed as p 
≤ 0.05. 
 
 
Figure 4. Effect of 40 g/die of hazelnuts on LDL-ox. The 
values of oxidized LDL show a significant decrease (p ≤ 
0.005) with the combination of hazelnuts. The value found 
with the standard meal in association with hazelnuts was 
36.99 ± 5.45 U/l (min 28.58 - max 47.75), meanwhile the 
consumption of the meal without hazelnuts showed an av- 
erage value of 40.38 ± 6.02 (min 33.95 - min 50.58). 
 
852/2004) system is the internationally agreed approach 
to food safety control; in the prevention of foodborne 
illnesses the “from farm to fork” food chain the official 
checks performed by the competent authorities involved 
in assuring food quality may be not sufficient, since it is 
necessary to follow the nutrient throughout the chain that 
goes “from farm to the consumer”. In order to implement 
HACCP, we performed a new process not only for food 
safety, but also for food quality. The NACCP is based on 
the principle that food has to be considered in a complete 
manner, targeting both safety and nutritional aspects, 
since increased awareness in both sectors generally en- 
courages healthy eating and good habits, and prevents 
acute and chronic diseases [4]. This double intervention is 
innovative and no other similar processes have been done 
in Italy or worldwide. We applied the NACCP process to 
hazelnut food chain, using TPC and TAC as biomarker 
for the traceability of nutritional quality, in order to verify 
the effects of hazelnut consumption. Hazelnuts have a 
number of cardioprotective compounds including vitamin 
E (alpha-tocopherol isomer), phytosterols, vitamin B6, 
folate, L-arginine, polyphenols and fiber. In addition, it is 
the second richest source of Monounsaturated Fatty Acids 
(MUFAs) among nuts. It contains approximately 82% - 83% 
MUFAs, mainly oleic acid (18:1) and less than 7.7% - 8% 
saturated fatty acids (SFA) [24]. Hazelnuts can be consi- 
dered as a good source of phenolic compounds. In the 
hazelnut sample used for the study the TPC was higher 
respect to TPC values found in fruits of major species 
such as apple, pear, nectarine, kiwifruit and in the kernel 
of other important nut species such as almond and nut pine, 
but lower respect to berry fruits and walnut, known to be 
excellent sources of bioactive compounds [25]. Contrary 
to most fruit species, hazelnut can be stored in appropri- 
ate conditions for over a year maintaining unaltered the 
sensory, physical and nutraceutical characteristics [20]. 
This makes the product easily available during all the 
year both for the direct consumption and for the food 
industry to be used in confectionery, increasing the con- 
sumption sources. In raw hazelnut, as in other nuts with 
the exception of walnut, the pellicle contains more than 
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50% of the total antioxidants and the cultivation man- 
agement, storage conditions (in shell or shelled, temper- 
ature and atmosphere conditions) and genotype affects 
the content of total antioxidants. For this reason it is im- 
portant to assess the quality and origin of the product 
consumed to optimized the diet and the effect of the ha- 
zelnut consumption on human health. The hazelnut cul- 
tivar used in this study was confirmed to be “Tonda Gen- 
tile delle Langhe”, recently renamed “Tonda Gentile 
Trilobata” and protected under the PGI “Nocciola Pie- 
monte”; it is particularly appreciated for its qualitative 
parameters such as the ease of pellicle removal, the good 
shelf life and the excellent flavour after roasting. In ac-
cordance with the results of Alasalvar et al. [26], in our 
analysis the most abundant minerals in nuts are potassium, 
calcium, magnesium, selenium, iron and zinc. Pollutants 
were also analyzed that can be harmful to human health. 
The levels of lead [Reg EU 1881/2006] and aflatoxins 
[Reg EU 165/2010] found within acceptable limits. Many 
studies [27] have investigated the effects of diets con- 
taining nuts on marker of endothelial function or in- 
flammation, but to our knowledge there are no studies that 
analyze the effect of the nutrigenomic hazelnut on human 
beings. When LDL is oxidized, it is even more athero- 
genic and plays an important role in the pathogenesis of 
atherosclerosis [28]. Monousaturated fatty acids have 
been reported to have hypolipidemic effects [29]. In this 
study, we found a significant lowering of LDL oxidized 
proteins, in association with the consumption of 40 g/d of 
hazelnuts. As reported by Yücesan et al. [30], α-toco- 
pherol is lipid soluble and therefore, able to travel within 
the LDL particle and indeed costitutes the main antioxi- 
dant species directly coating the LDL particle surface. It 
can inhibit radical chain propagation by scavenging 
highly reactive lipid peroxyl and alkoxyl radicals, which 
promote the propagation of the chain reaction of lipid 
peroxidation [31]. It may be suggested that high MUFA 
and tocopherol content of a hazelnut-enriched diet could 
be responsible for decrease in the susceptibility of LDL to 
oxidation. Particularly significant is the change in body 
water, and extracellular total hip circumference (p ≤ 0.05) 
of consumer after standard diet with 40 g/die of hazelnut. 
It should be noted, also, one significant deviation of the 
value of hip circumference between the initial phase of 
fasting and the one immediately after the antioxidant diet 
period (p ≤ 0.05). Introduction in the diet of some spe- 
cific nutrient could modulate the expression profiles of 
specific genes involved in the antioxidant defense me- 
chanism. Peripheral blood mononuclear cells (PBMCs) 
were used for gene expression studies, because they can 
be easily collected in contrast to other tissues [32]. 
However, gene modulation in PBMCs has not sufficient- 
ly been investigated in the context of human oxidative 
stress, inflammation, CHD, CAD and diet. To determine 
whether hazelnut consumption has an antioxidant effect 
on gene expression profile, we conducted a qRT-PCR 
array of 84 genes related to antioxidant defenses and 
oxidative stress pathway in human PBMC before and 
after 40 days of 40 g/d hazelnuts supplementation in a 
standardized diet. After data normalization, we found 11 
statistically significant genes differentially expressed (p 
≤ 0.005). Each of them has a unique function in fighting 
oxidative stress and they act synergistically to combat the 
oxidative stress implicated for example in atherosclerosis. 
It was interesting to note that some of the up-regulated 
genes are antioxidant genes; between the antioxidant 
enzymes that we found up-regulated after hazelnut diet 
intervention we have GPX2, GSR and HSPA1A. GPX2 
gene is a member of the glutathione peroxidase family 
and encodes a selenium-dependent glutathione perox- 
idase that is one of two isoenzymes responsible for the 
majority of the glutathione-dependent hydrogen perox- 
ide-reducing activity in the epithelium of the gastrointes- 
tinal tract. Our finding of an up-regulation of GPX2 gene 
after hazelnuts consumption may suggest that the anti- 
oxidant effect of hazelnut biochemical compounds could 
be related to an increase of this antioxidant enzyme at 
transcription level, indicating a protective effect against 
inflamation, oxidative stress and atherogenesis. GSR is a 
gene encoding a member of the class-I pyridine nucleo- 
tide-disulfide oxidoreductase family. It is a central en- 
zyme of cellular antioxidant defense and reduces gluta- 
thione disulfide to the sulfhydryl form, glutathione, 
which is an important cellular antioxidant. In a recent 
paper [33] evaluating the oxidative stress (OS) status in 
subjects with different cardiovascular risk factors, the 
antioxidant activity of cytoplasmic enzymes was reduced. 
In our work the transcription levels of GSR were in- 
creased after hazelnut consumption (p ≤ 0.05), suggest- 
ing a protective role against oxidative stress and athero- 
genic process. Our results could be in part supported by 
the recent work of Wu X. et al. [34,35] in which they 
found that an up-regulation of GSR gene in mice with 
diet enriched of blueberry indicated a protective role of 
these fruits against oxidative stress. This result could be 
easily compared with our result in which we found an 
up-regulation of GSR in subjects with a diet enriched of 
hazelnuts. TXNRD1 is another antioxidant gene that we 
found up-regulated after hazelnuts introduction in the diet. 
This gene encoded a protein that regenerates reduced thi- 
oredoxin, which serves as reducing equivalent, and may 
also directly reduce lipid hydroperoxides [36]. Moreover, 
we found that some of the downregulated genes CCL5, 
KRT1, MBL2 are pro-oxidant genes. CCL5 gene is one of 
several chemokine genes clustered on the q-arm of chro- 
mosome 17. In Yin-Ling Lin et al. [36,37] paper, the au- 
thors suggested that the antioxidant used in their work effec- 
tively suppressed CCL5 mRNA expression levels, 
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indicating that oxidant may be involved in the induction 
of the CCL5 gene expression by dengue-2-virus infection. 
In our work we found that the transcription levels of this 
genes were decreased (p ≤ 0.05) after hazelnut consump-
tion. A particular trend about the gene expression was 
found for 2 genes: SOD1 which was an antioxidant en-
zyme that in our analysis was found down-regulated after 
hazelnut consumption and HSPA1A is a stress protein 
that is significantly induced by oxidative stress [38] 
which could be considered a pro-oxidant factor that was 
found up-regulated in our work. These 2 genes displayed 
a trend that was contrary to what we could expect. We 
found that SOD1, which is an antioxidant gene, was 
down-regulated (p ≤ 0.05) and HSPA1A which is a 
prooxidant gene result up-regulated (p ≤ 0.05) respec- 
tively. SOD1 is the major cellular defense enzyme 
against superoxides in vascular cells. This gene encodes 
a protein that binds copper and zinc ions and is one of 
two isozymes responsible for destroying free superoxide 
radicals in the body. The encoded isozyme is a soluble 
cytoplasmic protein, acting as a homodimer to convert 
naturally occuring but harmful superoxide radicals to 
molecular oxygen and hydrogen peroxide [39]. Inducible 
HSP genes can be up-regulated by a wide range of cellu- 
lar stresses. There is a strong evidence that the induction 
of HSPs coincides with the acquisition of tolerance to 
stress, which could otherwise lead to cell death. In our 
work we found that the gene expression levels of these 
two genes (KRT1 and MBL2) were down-regulated after 
the daily hazelnut consumption, suggesting that probably 
there was a protective effect against the oxidative stress 
mediated by hazelnut functional biochemical compounds. 
Although it is acceptable for genomic studies a numerous- 
ity of 8 to 25 subjects, the data will be confirmed on a 
larger number of subjects. Furthermore, it will be ne- 
cessary to perform a follow up after 1, 3, 6 months to 
assess the persistence of the benefits on levels of LDL 
oxidation. 
5. Conclusion 
In conclusion, the nutritional quality of hazelnuts, 
identified by TPC and TAC is in a certain way trans- 
ferred to the consumer, as demonstrated by the results of 
gene expression and LDL oxidation, giving to diet the 
health qualities. This results support that the hypothesis 
NACCP process could be applied to obtain significant 
benefits in terms of primary prevention and contributing 
to the amelioration of food management at the consumer 
level. Moreover, it may be applied in agreement with 
Article 13.1 (EC) Regulation NO. 1924/2006 to nutrition 
and health claims referring to the role of a nutrient or sub- 
stance on: growth, development and body function; psy- 
chological and behavioral aspects. 
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